drugset / Trial / NCT04369846
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
Phase 1/2
Completed
76 enrolled
Xantho Biotechnology Co., LTD
Virginia Contract Research Organization Co., Ltd. · collab
RandomizedParallel-groupDouble-blindOther
Summary
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GM-XANTHO in Healthy Volunteers and to Investigate its Efficacy and Safety Profile in Atopic Dermatitis Patients
Timeline
- Start
- 2020-05-04
- Primary completion
- 2025-01-22
- Completion
- 2025-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GM-XANTHO | Unknown | — | — |